WO2010063030A3 - Dermal application of vasoconstrictors - Google Patents
Dermal application of vasoconstrictors Download PDFInfo
- Publication number
- WO2010063030A3 WO2010063030A3 PCT/US2009/066124 US2009066124W WO2010063030A3 WO 2010063030 A3 WO2010063030 A3 WO 2010063030A3 US 2009066124 W US2009066124 W US 2009066124W WO 2010063030 A3 WO2010063030 A3 WO 2010063030A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vasoconstrictors
- dermal application
- disclosed
- vasocontrictor
- onset
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Surgery (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
There is disclosed the topical dermal use of vasocontrictor substances for regulating body temperature to treat, prevent or delay the onset of anesthetic induced hypothermia. Kits containing appropriate materials and instructions, and other embodiments, are also disclosed.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09829849A EP2376073A2 (en) | 2008-11-30 | 2009-11-30 | Dermal application of vasoconstrictors |
CN2009801558027A CN102300566A (en) | 2008-11-30 | 2009-11-30 | Dermal Application Of Vasoconstrictors |
US12/982,117 US20110144209A1 (en) | 2008-06-30 | 2010-12-30 | Use of vasoconstrictors |
US13/118,563 US20120095104A1 (en) | 2008-11-30 | 2011-05-30 | Use of vasoconstrictors |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11861208P | 2008-11-30 | 2008-11-30 | |
US61/118,612 | 2008-11-30 | ||
PCT/IL2009/000652 WO2010001391A1 (en) | 2008-06-30 | 2009-06-30 | Dermal application of vasoconstrictors |
ILPCT/IL2009/000652 | 2009-06-30 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2009/000652 Continuation-In-Part WO2010001391A1 (en) | 2008-06-30 | 2009-06-30 | Dermal application of vasoconstrictors |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2009/000652 Continuation-In-Part WO2010001391A1 (en) | 2008-06-30 | 2009-06-30 | Dermal application of vasoconstrictors |
US12/982,117 Continuation-In-Part US20110144209A1 (en) | 2008-06-30 | 2010-12-30 | Use of vasoconstrictors |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010063030A2 WO2010063030A2 (en) | 2010-06-03 |
WO2010063030A3 true WO2010063030A3 (en) | 2011-04-21 |
Family
ID=42226391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/066124 WO2010063030A2 (en) | 2008-06-30 | 2009-11-30 | Dermal application of vasoconstrictors |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2376073A2 (en) |
CN (1) | CN102300566A (en) |
WO (1) | WO2010063030A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013043985A1 (en) | 2011-09-23 | 2013-03-28 | The Regents Of The University Of California | Edible oils to enhance delivery of orally administered steroids |
CN112472814A (en) | 2012-01-23 | 2021-03-12 | 萨奇治疗股份有限公司 | Neuroactive steroid formulations and methods of treating central nervous system disorders |
RU2667010C2 (en) * | 2012-08-21 | 2018-09-13 | Сейдж Терапьютикс, Инк. | Methods of treatment of epilepsy or status epilepticus |
EP4335505A3 (en) | 2012-11-30 | 2024-06-05 | The Regents of The University of California | Anticonvulsant activity of steroids |
US20150098997A1 (en) | 2013-10-07 | 2015-04-09 | Teikoku Pharma Usa, Inc. | Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions |
RU2018105761A (en) | 2013-10-07 | 2019-02-26 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | DEVICES FOR TRANSDERMAL DELIVERY OF DEXMEDETOMIDIDINE AND WAYS OF THEIR APPLICATION |
KR101891185B1 (en) | 2013-10-07 | 2018-08-24 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine |
CN109414444A (en) | 2016-03-08 | 2019-03-01 | 萨奇治疗股份有限公司 | Neuroactive steroids, its composition and purposes |
WO2018123982A1 (en) * | 2016-12-26 | 2018-07-05 | 久光製薬株式会社 | Microneedle device |
-
2009
- 2009-11-30 EP EP09829849A patent/EP2376073A2/en not_active Withdrawn
- 2009-11-30 CN CN2009801558027A patent/CN102300566A/en active Pending
- 2009-11-30 WO PCT/US2009/066124 patent/WO2010063030A2/en active Application Filing
Non-Patent Citations (1)
Title |
---|
ALFONSI P.: "Postanaesthetic shivering. Epidemiology, pathophysiology, and approaches to prevention and management", MINERVA ANESTESIOLOGICA, vol. 69, no. 5, May 2003 (2003-05-01), pages 438 - 442, XP008141457 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010063030A2 (en) | 2010-06-03 |
EP2376073A2 (en) | 2011-10-19 |
CN102300566A (en) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010063030A3 (en) | Dermal application of vasoconstrictors | |
WO2007090068A3 (en) | Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif) | |
WO2010003935A3 (en) | Temperature reducing, healing wound dressing | |
HRP20130387T1 (en) | Preparation for wound healing and prevention of bandage adhesion to the wound, containing chitosan-glucan | |
WO2007143098A3 (en) | Hepatocyte growth factor (hgf) binding proteins | |
WO2007143090A3 (en) | Hepatocyte growth factor (hgf) binding proteins | |
MY169564A (en) | Substituted dihydropyrazolones and their use | |
WO2010068794A3 (en) | Hif inhibitors and use thereof | |
WO2008079245A3 (en) | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof | |
WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
DE502006002304D1 (en) | Topical cosmetic formulations for regulating and improving the moisture content of the skin | |
WO2011143318A3 (en) | Anti-fgfr2 antibodies | |
EP4275752A3 (en) | Treatment of addiction and impulse-control disorders using pde7 inhibitors | |
EP4249001A3 (en) | Topical gels | |
WO2011085162A3 (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof | |
AU2007211617A1 (en) | Hydrogel | |
WO2010036395A3 (en) | Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds | |
GB2476202A (en) | Novel choline cocrystal of epalrestat | |
MY182983A (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
WO2008006226A8 (en) | Transdermal formulations of synthetic cannabinoids and nano colloidal silica | |
WO2009031099A3 (en) | Cosmetic use of microorganisms | |
WO2008070859A3 (en) | Treatment of skin conditions by dickkopf1 (dkk1) | |
BRPI0520258A2 (en) | use of a pharmaceutical composition, method for preparing a pharmaceutical composition, and use of an effective amount of eslicarbazepine acetate | |
WO2010065194A3 (en) | Compositions and methods for promoting a relaxation state | |
WO2010135131A3 (en) | Single-use, disposable strip for application of topical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980155802.7 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009829849 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09829849 Country of ref document: EP Kind code of ref document: A2 |